661 related articles for article (PubMed ID: 28754693)
1. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
[TBL] [Abstract][Full Text] [Related]
2. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
3. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
Front Immunol; 2021; 12():631797. PubMed ID: 33815382
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of procyanidin B1 on LPS-treated THP1 cells via interaction with the TLR4-MD-2 heterodimer and p38 MAPK and NF-κB signaling.
Xing J; Li R; Li N; Zhang J; Li Y; Gong P; Gao D; Liu H; Zhang Y
Mol Cell Biochem; 2015 Sep; 407(1-2):89-95. PubMed ID: 26037075
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
Mishra V; Pathak C
J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
[TBL] [Abstract][Full Text] [Related]
6. Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin.
Furuta T; Imajo-Ohmi S; Fukuda H; Kano S; Miyake K; Watanabe N
Eur J Immunol; 2008 May; 38(5):1341-50. PubMed ID: 18398934
[TBL] [Abstract][Full Text] [Related]
7. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
8. C4b-binding protein negatively regulates TLR4/MD-2 response but not TLR3 response.
Morita N; Yamazaki T; Murakami Y; Fukui R; Yamai I; Ichimonji I; Nakashima A; Nagaoka F; Takagi H; Miyake K; Akashi-Takamura S
FEBS Lett; 2017 Jun; 591(12):1732-1741. PubMed ID: 28542817
[TBL] [Abstract][Full Text] [Related]
9. Ergosta-7, 9 (11), 22-trien-3β-ol Interferes with LPS Docking to LBP, CD14, and TLR4/MD-2 Co-Receptors to Attenuate the NF-κB Inflammatory Pathway
Hsieh WT; Hsu MH; Lin WJ; Xiao YC; Lyu PC; Liu YC; Lin WY; Kuo YH; Chung JG
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204506
[TBL] [Abstract][Full Text] [Related]
10. Sulfatides are endogenous ligands for the TLR4-MD-2 complex.
Su L; Athamna M; Wang Y; Wang J; Freudenberg M; Yue T; Wang J; Moresco EMY; He H; Zor T; Beutler B
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34290146
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel binding to human and murine MD-2.
Zimmer SM; Liu J; Clayton JL; Stephens DS; Snyder JP
J Biol Chem; 2008 Oct; 283(41):27916-27926. PubMed ID: 18650420
[TBL] [Abstract][Full Text] [Related]
12. The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane.
Tanimura N; Saitoh S; Ohto U; Akashi-Takamura S; Fujimoto Y; Fukase K; Shimizu T; Miyake K
Int Immunol; 2014 Jun; 26(6):307-14. PubMed ID: 24380872
[TBL] [Abstract][Full Text] [Related]
13. A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation.
Marshall JD; Heeke DS; Rao E; Maynard SK; Hornigold D; McCrae C; Fraser N; Tovchigrechko A; Yu L; Williams N; King S; Cooper ME; Hajjar AM; Woo JC
PLoS One; 2016; 11(10):e0164632. PubMed ID: 27736941
[TBL] [Abstract][Full Text] [Related]
14. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.
Ben Haij N; Planès R; Leghmari K; Serrero M; Delobel P; Izopet J; BenMohamed L; Bahraoui E
PLoS One; 2015; 10(6):e0129425. PubMed ID: 26090662
[TBL] [Abstract][Full Text] [Related]
16. Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.
Garate JA; Stöckl J; Fernández-Alonso Mdel C; Artner D; Haegman M; Oostenbrink C; Jiménez-Barbero J; Beyaert R; Heine H; Kosma P; Zamyatina A
Innate Immun; 2015 Jul; 21(5):490-503. PubMed ID: 25394365
[TBL] [Abstract][Full Text] [Related]
17. A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway.
Tundup S; Srivastava L; Norberg T; Watford W; Harn D
PLoS One; 2015; 10(9):e0137495. PubMed ID: 26340260
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.
Rallabhandi P; Phillips RL; Boukhvalova MS; Pletneva LM; Shirey KA; Gioannini TL; Weiss JP; Chow JC; Hawkins LD; Vogel SN; Blanco JC
mBio; 2012; 3(4):. PubMed ID: 22872782
[TBL] [Abstract][Full Text] [Related]
19. Unique properties of the chicken TLR4/MD-2 complex: selective lipopolysaccharide activation of the MyD88-dependent pathway.
Keestra AM; van Putten JP
J Immunol; 2008 Sep; 181(6):4354-62. PubMed ID: 18768894
[TBL] [Abstract][Full Text] [Related]
20. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
